{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T01:20:03Z","timestamp":1787620803704,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,24]]},"DOI":"10.7759\/cureus.115114","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T01:07:00Z","timestamp":1787620020000},"source":"Crossref","is-referenced-by-count":0,"title":["Contralateral Primary Small-Cell Neuroendocrine Carcinoma of the Breast With Focal Squamous Differentiation in a Patient With Prior Invasive Ductal Carcinoma: A Rare Case"],"prefix":"10.7759","author":[{"given":"Erik L","family":"Parkhurst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Hamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.848485","article-title":"Primary neuroendocrine tumor of the breast: current understanding and future perspectives","volume":"12","author":"Sun H","year":"2022","unstructured":"Sun H, Dai S, Xu J, Liu L, Yu J, Sun T. Primary neuroendocrine tumor of the breast: current understanding and future perspectives. Front Oncol. 2022, 12:848485. 10.3389\/fonc.2022.848485","journal-title":"Front Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/his.70149","article-title":"World Health Organization classification of tumours of the breast 6th edition 2026","volume":"89","author":"Quinn C","year":"2026","unstructured":"Quinn C, Tan PH, Allison KH, et al.. World Health Organization classification of tumours of the breast 6th edition 2026. Histopathology. 2026, 89:199-218. 10.1111\/his.70149","journal-title":"Histopathology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4132\/jptm.2022.04.25","article-title":"What's new in breast pathology 2022: WHO 5th edition and biomarker updates","volume":"56","author":"Muller K","year":"2022","unstructured":"Muller K, Jorns JM, Tozbikian G. What's new in breast pathology 2022: WHO 5th edition and biomarker updates. J Pathol Transl Med. 2022, 56:170-1. 10.4132\/jptm.2022.04.25","journal-title":"J Pathol Transl Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2016-0364-RS","article-title":"Neuroendocrine tumors of the breast","volume":"141","author":"Rosen LE","year":"2017","unstructured":"Rosen LE, Gattuso P. Neuroendocrine tumors of the breast. Arch Pathol Lab Med. 2017, 141:1577-81. 10.5858\/arpa.2016-0364-RS","journal-title":"Arch Pathol Lab Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","article-title":"Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up","volume":"19","author":"Elston CW","year":"1991","unstructured":"Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991, 19:403-10. 10.1111\/j.1365-2559.1991.tb00229.x","journal-title":"Histopathology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2015.53964","article-title":"Retrospective evaluation of histopathological examinations in invasive ductal breast cancer of no special type: an analysis of 691 patients","volume":"13","author":"Badowska-Kozakiewicz AM","year":"2017","unstructured":"Badowska-Kozakiewicz AM, Liszcz A, Sobol M, Patera J. Retrospective evaluation of histopathological examinations in invasive ductal breast cancer of no special type: an analysis of 691 patients. Arch Med Sci. 2017, 13:1408-15. 10.5114\/aoms.2015.53964","journal-title":"Arch Med Sci"},{"key":"ref7","article-title":"Breast cancer","author":"Menon G","year":"2024","unstructured":"Menon G, Alkabban FM, Ferguson T. Breast cancer. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s44272-025-00030-6","article-title":"Rethinking contralateral breast cancer: latest insights on risk, prevention, and outcomes","volume":"4","author":"Hosseini MS","year":"2025","unstructured":"Hosseini MS. Rethinking contralateral breast cancer: latest insights on risk, prevention, and outcomes. Clin Cancer Bull. 2025, 4:3. 10.1007\/s44272-025-00030-6","journal-title":"Clin Cancer Bull"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08132-9","article-title":"Increased risk of breast cancer-specific mortality among cancer survivors who developed breast cancer as a second malignancy","volume":"21","author":"Wang C","year":"2021","unstructured":"Wang C, Hu K, Deng L, He W, Fang F, Tamimi RM, Lu D. Increased risk of breast cancer-specific mortality among cancer survivors who developed breast cancer as a second malignancy. BMC Cancer. 2021, 21:491. 10.1186\/s12885-021-08132-9","journal-title":"BMC Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31051","article-title":"Contralateral breast cancers: Independent cancers or metastases?","volume":"142","author":"Begg CB","year":"2018","unstructured":"Begg CB, Ostrovnaya I, Geyer FC, et al.. Contralateral breast cancers: Independent cancers or metastases?. Int J Cancer. 2018, 142:347-56. 10.1002\/ijc.31051","journal-title":"Int J Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-006-9270-3","article-title":"Bilateral breast cancer: clinical characteristics and prognostic factors","volume":"101","author":"Hartman M","year":"2007","unstructured":"Hartman M, Czene K, Reilly M, et al.. Bilateral breast cancer: clinical characteristics and prognostic factors. Breast Cancer Res Treat. 2007, 101:49-55. 10.1007\/s10549-006-9270-3","journal-title":"Breast Cancer Res Treat"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/path.4540","article-title":"Uncovering the genomic heterogeneity of multifocal breast cancer","volume":"236","author":"Desmedt C","year":"2015","unstructured":"Desmedt C, Fumagalli D, Pietri E, et al.. Uncovering the genomic heterogeneity of multifocal breast cancer. J Pathol. 2015, 236:457-66. 10.1002\/path.4540","journal-title":"J Pathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1023\/B:BREA.0000032921.10481.dc","article-title":"The role of MRI in invasive lobular carcinoma","volume":"86","author":"Boetes C","year":"2004","unstructured":"Boetes C, Veltman J, van Die L, Bult P, Wobbes T, Barentsz JO. The role of MRI in invasive lobular carcinoma. Breast Cancer Res Treat. 2004, 86:31-7. 10.1023\/B:BREA.0000032921.10481.dc","journal-title":"Breast Cancer Res Treat"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.12.2011.5343","article-title":"Neuroendocrine breast cancer","volume":"2012","author":"Gra\u00e7a S","year":"2012","unstructured":"Gra\u00e7a S, Esteves J, Costa S, Vale S, Maciel J. Neuroendocrine breast cancer. BMJ Case Rep. 2012, 2012:1220115343. 10.1136\/bcr.12.2011.5343","journal-title":"BMJ Case Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/204065","article-title":"Neuroendocrine tumor, well differentiated, of the breast: a relatively high-grade case in the histological subtype","volume":"2013","author":"Tajima S","year":"2013","unstructured":"Tajima S, Horiuchi H. Neuroendocrine tumor, well differentiated, of the breast: a relatively high-grade case in the histological subtype. Case Rep Pathol. 2013, 2013:204065. 10.1155\/2013\/204065","journal-title":"Case Rep Pathol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-010-1178-3","article-title":"Solid neuroendocrine carcinomas of the breast: metastases or primary tumors?","volume":"124","author":"Richter-Ehrenstein C","year":"2010","unstructured":"Richter-Ehrenstein C, Arndt J, Buckendahl AC, et al.. Solid neuroendocrine carcinomas of the breast: metastases or primary tumors?. Breast Cancer Res Treat. 2010, 124:413-7. 10.1007\/s10549-010-1178-3","journal-title":"Breast Cancer Res Treat"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-010-4516-5","article-title":"Bilateral primary breast neuroendocrine carcinoma in a young woman: report of a case","volume":"41","author":"Zhang JY","year":"2011","unstructured":"Zhang JY, Chen WJ. Bilateral primary breast neuroendocrine carcinoma in a young woman: report of a case. Surg Today. 2011, 41:1575-8. 10.1007\/s00595-010-4516-5","journal-title":"Surg Today"},{"key":"ref18","article-title":"Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling","volume":"20","author":"L\u00f3pez-Bonet E","year":"2008","unstructured":"L\u00f3pez-Bonet E, Alonso-Ruano M, Barraza G, Vazquez-Martin A, Bernad\u00f3 L, Menendez JA. Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling. Oncol Rep. 2008, 20:1369-74.","journal-title":"Oncol Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.2012.01970.x","article-title":"Metastatic small cell neuroendocrine carcinoma of the breast","volume":"39","author":"Boyd AS","year":"2012","unstructured":"Boyd AS, Hayes BB. Metastatic small cell neuroendocrine carcinoma of the breast. J Cutan Pathol. 2012, 39:1042-6. 10.1111\/j.1600-0560.2012.01970.x","journal-title":"J Cutan Pathol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25352","article-title":"Invasive neuroendocrine carcinoma of the breast: a distinctive subtype of aggressive mammary carcinoma","volume":"116","author":"Wei B","year":"2010","unstructured":"Wei B, Ding T, Xing Y, et al.. Invasive neuroendocrine carcinoma of the breast: a distinctive subtype of aggressive mammary carcinoma. Cancer. 2010, 116:4463-73. 10.1002\/cncr.25352","journal-title":"Cancer"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1053\/j.semdp.2009.12.003","article-title":"Neuroendocrine differentiation in breast cancer: established facts and unresolved problems","volume":"27","author":"Righi L","year":"2010","unstructured":"Righi L, Sapino A, Marchi\u00f2 C, Papotti M, Bussolati G. Neuroendocrine differentiation in breast cancer: established facts and unresolved problems. Semin Diagn Pathol. 2010, 27:69-76. 10.1053\/j.semdp.2009.12.003","journal-title":"Semin Diagn Pathol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/or.2024.12114","article-title":"Management of neuroendocrine breast carcinoma (NEBC): review of literature","volume":"18","author":"Mohamed A","year":"2024","unstructured":"Mohamed A, Zeidalkilani J, Asa SL, Trybula M, Montero AJ. Management of neuroendocrine breast carcinoma (NEBC): review of literature. Oncol Rev. 2024, 18:12114. 10.3389\/or.2024.12114","journal-title":"Oncol Rev"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2017.107","article-title":"Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast","volume":"31","author":"Lavigne M","year":"2018","unstructured":"Lavigne M, Menet E, Tille JC, et al.. Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast. Mod Pathol. 2018, 31:68-82. 10.1038\/modpathol.2017.107","journal-title":"Mod Pathol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/jscr\/rjz182","article-title":"Primary squamous cell carcinoma of the breast: a case report and review of the literature","volume":"2019","author":"Anne N","year":"2019","unstructured":"Anne N, Sulger E, Pallapothu R. Primary squamous cell carcinoma of the breast: a case report and review of the literature. J Surg Case Rep. 2019, 2019:182. 10.1093\/jscr\/rjz182","journal-title":"J Surg Case Rep"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.10.3500","article-title":"Synaptophysin: a marker protein for neuroendocrine cells and neoplasms","volume":"83","author":"Wiedenmann B","year":"1986","unstructured":"Wiedenmann B, Franke WW, Kuhn C, Moll R, Gould VE. Synaptophysin: a marker protein for neuroendocrine cells and neoplasms. Proc Natl Acad Sci U S A. 1986, 83:3500-4. 10.1073\/pnas.83.10.3500","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-020-00505-9","article-title":"Insulinoma-associated protein 1 (INSM1): a potential biomarker and therapeutic target for neuroendocrine tumors","volume":"43","author":"Mahalakshmi B","year":"2020","unstructured":"Mahalakshmi B, Baskaran R, Shanmugavadivu M, Nguyen NT, Velmurugan BK. Insulinoma-associated protein 1 (INSM1): a potential biomarker and therapeutic target for neuroendocrine tumors. Cell Oncol (Dordr). 2020, 43:367-76. 10.1007\/s13402-020-00505-9","journal-title":"Cell Oncol (Dordr)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000138183.97366.fd","article-title":"p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma","volume":"28","author":"Koker MM","year":"2004","unstructured":"Koker MM, Kleer CG. p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma. Am J Surg Pathol. 2004, 28:1506-12. 10.1097\/01.pas.0000138183.97366.fd","journal-title":"Am J Surg Pathol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-021-03204-4","article-title":"Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implications","volume":"480","author":"V\u00f6lkel C","year":"2022","unstructured":"V\u00f6lkel C, De Wispelaere N, Weidemann S, et al.. Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implications. Virchows Arch. 2022, 480:433-47. 10.1007\/s00428-021-03204-4","journal-title":"Virchows Arch"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-011-1633-9","article-title":"Anti-cytokeratin CAM 5.2 (B.D. Biosciences) has a primary reactivity with CK 7 and CK 8 (48 and 52 kD) rather than with the smaller molecular weight keratin breakdown fractions (50, 43, and 38 kD)","volume":"130","author":"Yao CC","year":"2011","unstructured":"Yao CC, Lin WL, Lee MY, Han CP. Anti-cytokeratin CAM 5.2 (B.D. Biosciences) has a primary reactivity with CK 7 and CK 8 (48 and 52 kD) rather than with the smaller molecular weight keratin breakdown fractions (50, 43, and 38 kD). Breast Cancer Res Treat. 2011, 130:707-8. 10.1007\/s10549-011-1633-9","journal-title":"Breast Cancer Res Treat"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.12727","article-title":"Combination of GATA3, SOX-10, and PAX8 in a comprehensive panel to diagnose breast cancer metastases","volume":"36","author":"Na K","year":"2022","unstructured":"Na K, Woo HY, DO SI, Kim SW. Combination of GATA3, SOX-10, and PAX8 in a comprehensive panel to diagnose breast cancer metastases. In Vivo. 2022, 36:473-81. 10.21873\/invivo.12727","journal-title":"In Vivo"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1177\/1066896916656444","article-title":"High-grade neuroendocrine carcinoma of the breast with focal squamous differentiation","volume":"24","author":"Me\u010diarov\u00e1 I","year":"2016","unstructured":"Me\u010diarov\u00e1 I, Soj\u00e1kov\u00e1 M, Mego M, Mardiak J, Pohlodek K. High-grade neuroendocrine carcinoma of the breast with focal squamous differentiation. Int J Surg Pathol. 2016, 24:738-42. 10.1177\/1066896916656444","journal-title":"Int J Surg Pathol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/dc.25427","article-title":"Fine Needle aspiration cytological diagnosis of Primary Breast Large-Cell neuroendocrine carcinoma\/squamous cell carcinoma","volume":"53","author":"Cui W","year":"2025","unstructured":"Cui W, Yang C, Ding X, Liu J, Zhang H, Xu H. Fine Needle aspiration cytological diagnosis of Primary Breast Large-Cell neuroendocrine carcinoma\/squamous cell carcinoma. Diagn Cytopathol. 2025, 53:38-45. 10.1002\/dc.25427","journal-title":"Diagn Cytopathol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2023.108813","article-title":"Primary neuroendocrine carcinoma of the breast in association with squamous cell carcinoma of the breast: a case report and review of the literature","volume":"111","author":"Younes B","year":"2023","unstructured":"Younes B, Zakaria B, Doha K, Mustapha B, Simohamed E, Mohamed EK. Primary neuroendocrine carcinoma of the breast in association with squamous cell carcinoma of the breast: a case report and review of the literature. Int J Surg Case Rep. 2023, 111:108813. 10.1016\/j.ijscr.2023.108813","journal-title":"Int J Surg Case Rep"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/his.12201","article-title":"Small-cell carcinoma of the breast with squamous differentiation","volume":"63","author":"Kawasaki T","year":"2013","unstructured":"Kawasaki T, Bussolati G, Castellano I, et al.. Small-cell carcinoma of the breast with squamous differentiation. Histopathology. 2013, 63:739-41. 10.1111\/his.12201","journal-title":"Histopathology"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.13104\/imri.2022.26.3.161","article-title":"Primary small cell neuroendocrine carcinoma of the breast: a case report with literature review","volume":"26","author":"Han YJ","year":"2022","unstructured":"Han YJ, Kim YM, Kim HJ. Primary small cell neuroendocrine carcinoma of the breast: a case report with literature review. Investig Magn Reson Imaging. 2022, 26:161-5. 10.13104\/imri.2022.26.3.161","journal-title":"Investig Magn Reson Imaging"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215109991228","article-title":"Primary, combined, atypical carcinoid and squamous cell carcinoma of the larynx: a new variety of composite tumour","volume":"124","author":"Davies-Husband CR","year":"2010","unstructured":"Davies-Husband CR, Montgomery P, Premachandra D, Hellquist H. Primary, combined, atypical carcinoid and squamous cell carcinoma of the larynx: a new variety of composite tumour. J Laryngol Otol. 2010, 124:226-9. 10.1017\/S0022215109991228","journal-title":"J Laryngol Otol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1159\/000526337","article-title":"Combined large-cell neuroendocrine and squamous cell carcinoma of the uterine cervix with a personal history of the primary breast duct carcinoma in situ: a clinicopathological characteristic and outcome","volume":"15","author":"Le DT","year":"2022","unstructured":"Le DT, Do KH, Do TA, Bui HT, Nguyen CV. Combined large-cell neuroendocrine and squamous cell carcinoma of the uterine cervix with a personal history of the primary breast duct carcinoma in situ: a clinicopathological characteristic and outcome. Case Rep Oncol. 2022, 15:770-5. 10.1159\/000526337","journal-title":"Case Rep Oncol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2013.11.005","article-title":"Neuroendocrine breast tumours: breast cancer or neuroendocrine cancer presenting in the breast?","volume":"23","author":"Adams RW","year":"2014","unstructured":"Adams RW, Dyson P, Barthelmes L. Neuroendocrine breast tumours: breast cancer or neuroendocrine cancer presenting in the breast?. Breast. 2014, 23:120-7. 10.1016\/j.breast.2013.11.005","journal-title":"Breast"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-012-0222-z","article-title":"Primary neuroendocrine breast cancer, how much do we know so far?","volume":"29","author":"Alkaied H","year":"2012","unstructured":"Alkaied H, Harris K, Azab B, Dai Q. Primary neuroendocrine breast cancer, how much do we know so far?. Med Oncol. 2012, 29:2613-8. 10.1007\/s12032-012-0222-z","journal-title":"Med Oncol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1186\/s40064-015-0913-y","article-title":"A population-based analysis of outcomes for small cell carcinoma of the breast by tumor stage and the use of radiation therapy","volume":"4","author":"Hare F","year":"2015","unstructured":"Hare F, Giri S, Patel JK, Hahn A, Martin MG. A population-based analysis of outcomes for small cell carcinoma of the breast by tumor stage and the use of radiation therapy. Springerplus. 2015, 4:138. 10.1186\/s40064-015-0913-y","journal-title":"Springerplus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/524697-contralateral-primary-small-cell-neuroendocrine-carcinoma-of-the-breast-with-focal-squamous-differentiation-in-a-patient-with-prior-invasive-ductal-carcinoma-a-rare-case","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T01:07:01Z","timestamp":1787620021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/524697-contralateral-primary-small-cell-neuroendocrine-carcinoma-of-the-breast-with-focal-squamous-differentiation-in-a-patient-with-prior-invasive-ductal-carcinoma-a-rare-case"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":40,"URL":"https:\/\/doi.org\/10.7759\/cureus.115114","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,24]]}}}